Zobrazeno 1 - 10
of 128
pro vyhledávání: '"Takahiko, Sugihara"'
Autor:
Zento Yamada, Sei Muraoka, Mai Kawazoe, Wataru Hirose, Hajime Kono, Shinsuke Yasuda, Takahiko Sugihara, Toshihiro Nanki
Publikováno v:
Arthritis Research & Therapy, Vol 26, Iss 1, Pp 1-12 (2024)
Abstract Background We aimed to reveal the effect of abatacept (ABT) on atherosclerosis in rheumatoid arthritis (RA) patients, 3-year efficacy for arthritis, and safety in a population of older vs. younger patients. Methods In this open-label, prospe
Externí odkaz:
https://doaj.org/article/66bd378468e44200b0483f51d774dde9
Autor:
Keigo Sugisawa, Hiroshi Takase, Takahiko Sugihara, Tetsuya Saito, Yuko Iwasaki, Koju Kamoi, Tatsushi Kawaguchi, Shinsuke Yasuda, Kyoko Ohno-Matsui
Publikováno v:
Case Reports in Ophthalmology, Vol 14, Iss 1, Pp 214-222 (2023)
We report a rare case of severe exudative retinal detachment with orbital granuloma associated with granulomatosis with polyangiitis (GPA). A 42-year-old man developed bilateral conjunctival hyperemia and eye pain 15 months before presenting to us. B
Externí odkaz:
https://doaj.org/article/6a286e2f8a2a49eeb4b0693c48022e45
Autor:
Masayo Kojima, Yutaka Kawahito, Takahiko Sugihara, Toshihisa Kojima, Ryozo Harada, Shintaro Hirata, Motomu Hashimoto, Toshihiko Hidaka, Hajime Ishikawa, Hiromu Ito, Mitsumasa Kishimoto, Yuko Kaneko, Kazuo Matsui, Toshihiro Matsui, Isao Matsushita, Akio Morinobu, Keiichiro Nishida, Eiichi Tanaka, Asami Abe, Michinori Ishitoku, Shuji Asai, Takashi Kida, Akira Onishi, Satoshi Takanashi, Masayoshi Harigai
Publikováno v:
BMC Rheumatology, Vol 6, Iss 1, Pp 1-8 (2022)
Abstract Background Although drug treatment strategies for rheumatoid arthritis (RA) are relatively well established, there is a paucity of evidence on the treatment in older patients. The purpose of this study is to build a registry for late-onset R
Externí odkaz:
https://doaj.org/article/85626547eb7d40baa3a7fcf9140c45f1
Autor:
Mariko Mouri, Mitsuru Imamura, Shotaro Suzuki, Tatsuya Kawasaki, Yoshiki Ishizaki, Keiichi Sakurai, Hiroko Nagafuchi, Norihiro Matsumura, Marina Uchida, Takayasu Ando, Kohei Yoshioka, Seido Ooka, Takahiko Sugihara, Hiroshi Miyoshi, Masaaki Mori, Tomoyuki Okada, Masao Yamaguchi, Hiroyuki Kunishima, Motohiro Kato, Kimito Kawahata
Publikováno v:
Allergology International, Vol 71, Iss 4, Pp 512-519 (2022)
Background: The mechanism of allergic reactions to COVID-19 mRNA vaccines has not been clarified. Polyethylene glycol (PEG) is a potential antigen in the components of vaccines. However, there is little evidence that allergy after COVID-19 mRNA vacci
Externí odkaz:
https://doaj.org/article/487d8d69a5f24176855c9716279742e8
Autor:
Fumiaki Kondo, Takahiko Sugihara, Natsuka Umezawa, Hisanori Hasegawa, Tadashi Hosoya, Naoki Kimura, Masaaki Mori, Shinsuke Yasuda
Publikováno v:
Arthritis Research & Therapy, Vol 24, Iss 1, Pp 1-10 (2022)
Abstract Background High-dose glucocorticoids (GC) are first-line treatment for adult-onset Still’s disease (AOSD); however, some of the patients remain refractory to initial GC therapy, or rapidly relapse. The aim of this study was to identify pro
Externí odkaz:
https://doaj.org/article/f8e8b13060c94fbea732d3d33a748cee
Autor:
Aya Kawasaki, Ken-ei Sada, Premita Ari Kusumawati, Fumio Hirano, Shigeto Kobayashi, Kenji Nagasaka, Takahiko Sugihara, Nobuyuki Ono, Takashi Fujimoto, Makio Kusaoi, Naoto Tamura, Yasuyoshi Kusanagi, Kenji Itoh, Takayuki Sumida, Kunihiro Yamagata, Hiroshi Hashimoto, Hirofumi Makino, Yoshihiro Arimura, Masayoshi Harigai, Naoyuki Tsuchiya
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundDisease relapse remains a major problem in the management of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). In European populations, HLA-DPB1*04:01 is associated with both susceptibility and relapse risk in proteina
Externí odkaz:
https://doaj.org/article/ef4229486aee43e3b9271dc944c7f708
Autor:
Mie Fusama, Hideko Nakahara, Misuzu Gregg, Yuriko Kuroe, Yukitomo Urata, Kimito Kawahata, Yutaka Kawahito, Masayo Kojima, Takahiko Sugihara, Motomu Hashimoto, Takako Miyamae, Atsuko Murashima, Masaaki Mori, Nobuyuki Yajima, Toshihiro Matsui
Publikováno v:
Modern Rheumatology; Jul2024, Vol. 34 Issue 4, p711-719, 9p
Autor:
Aya Kawasaki, Natsumi Namba, Ken-ei Sada, Fumio Hirano, Shigeto Kobayashi, Kenji Nagasaka, Takahiko Sugihara, Nobuyuki Ono, Takashi Fujimoto, Makio Kusaoi, Naoto Tamura, Kunihiro Yamagata, Takayuki Sumida, Hiroshi Hashimoto, Shoichi Ozaki, Hirofumi Makino, Yoshihiro Arimura, Masayoshi Harigai, Naoyuki Tsuchiya
Publikováno v:
Arthritis Research & Therapy, Vol 22, Iss 1, Pp 1-8 (2020)
Abstract Background Interstitial lung disease (ILD) is a severe complication with poor prognosis in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). Prevalence of AAV-associated ILD (AAV-ILD) in Japan is considerably higher th
Externí odkaz:
https://doaj.org/article/837710d4c12748c1a475a279387439a2
Autor:
Takahiko Sugihara, Hitoshi Hasegawa, Haruhito A. Uchida, Hajime Yoshifuji, Yoshiko Watanabe, Eisuke Amiya, Yasuhiro Maejima, Masanori Konishi, Yohko Murakawa, Noriyoshi Ogawa, Shunsuke Furuta, Yasuhiro Katsumata, Yoshinori Komagata, Taio Naniwa, Takahiro Okazaki, Yoshiya Tanaka, Tsutomu Takeuchi, Yoshikazu Nakaoka, Yoshihiro Arimura, Masayoshi Harigai, Mitsuaki Isobe, Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis (JPVAS)
Publikováno v:
Arthritis Research & Therapy, Vol 22, Iss 1, Pp 1-12 (2020)
Abstract Background Relapses frequently occur in giant cell arteritis (GCA), and long-term glucocorticoid therapy is required. The identification of associated factors with poor treatment outcomes is important to decide the treatment algorithm of GCA
Externí odkaz:
https://doaj.org/article/a56a7a3f6fa44f27ba6a48779a890401
Autor:
Akinori Hara, Ken-ei Sada, Takashi Wada, Koichi Amano, Hiroaki Dobashi, Tatsuya Atsumi, Takahiko Sugihara, Kouichi Hirayama, Shogo Banno, Yohko Murakawa, Midori Hasegawa, Kunihiro Yamagata, Yoshihiro Arimura, Hirofumi Makino, Masayoshi Harigai
Publikováno v:
Modern Rheumatology; Mar2024, Vol. 34 Issue 2, p382-390, 9p